Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.

Stefan D, Anker,; Bridget-Anne, Kirwan,; Veldhuisen, Dirk J, van; Gerasimos, Filippatos,; Josep, Comin-Colet,; Frank, Ruschitzka,; Thomas F, Lüscher,; Gregory P, Arutyunov,; Michael, Motro,; Claudio, Mori,; Bernard, Roubert,; Stuart J, Pocock,; Piotr, Ponikowski,

doi:10.1002/ejhf.823

Public

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.

Published in European journal of heart failure • Jan 1, 2018

Authors:

Anker, Stefan D

Kirwan, Bridget-Anne

van Veldhuisen, Dirk J

Abstract

AIMS: Iron deficiency (ID) is a common co-morbidity in patients with heart failure (HF) and has been suggested to be associated with poor prognosis. Recently completed double-blind randomised controlled trials (RCTs) studying HF patients with ID have shown improvements in functional capacity, sympto...

Subject

Chronic heart failure

Ferric carboxymaltose

Individual patient data meta-analysis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!